Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1616
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18458258 | INHALABLE COMPOSITION OF CLOFAZIMINE AND METHODS OF USE THEREOF | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17772187 | DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE | Non-Final OA | AstraZeneca AB |
| 18371682 | TRANSPARENT DRESSING WITH HYDROGEL LAYER | Non-Final OA | Dukal, LLC |
| 18524116 | Diketopiperazine Salts for Drug Delivery and Related Methods | Non-Final OA | MannKind Corporation |
| 17983915 | DRY POWDER INHALER | Non-Final OA | MannKind Corporation |
| 17244730 | DRY POWDER DRUG DELIVERY SYSTEM | Final Rejection | MannKind Corporation |
| 17158997 | DRY POWDER INHALER | Non-Final OA | MannKind Corporation |
| 18672318 | Inhalable Epinephrine Formulation | Non-Final OA | De Motu Cordis Pty Ltd |
| 17760354 | PRESSURED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION | Non-Final OA | CHIESI FARMACEUTICI S.P.A |
| 18639751 | METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO PROMOTE SOYBEAN GROWTH UNDER LOW LIGHT CONDITION | Non-Final OA | CH Biotech R&D Co., Ltd. |
| 18536211 | Method Of Using/Applying A Keratin Hydrolysis Peptide Solution Upon Wheat Plants To Promote Growth And Production Yield | Final Rejection | CH Biotech R&D Co., Ltd. |
| 18555813 | LYSINIBACILLUS BACTERIAL STRAIN THAT PROMOTES PLANT GROWTH, AND USE THEREOF | Non-Final OA | Kumiai Chemical Industry Co., Ltd. |
| 18616878 | PHARMACEUTICAL COMPOSITIONS COMPRISING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION | Non-Final OA | VERONA PHARMA PLC |
| 18552838 | MEANS AND METHOD FOR CYTOSOLIC DELIVERY | Non-Final OA | Universiteit Gent |
| 18606272 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | Non-Final OA | KINDEVA DRUG DELIVERY L.P. |
| 18590826 | COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY | Non-Final OA | AstraZeneca Pharmaceuticals LP |
| 18587616 | METHODS FOR THE CONTROL OF POA ANNUA IN WARM SEASON TURFGRASS USING THIENCARBAZONE-METHYL | Non-Final OA | Discovery Purchaser Corporation |
| 17969250 | PHARMACEUTICAL COMPOSITION | Final Rejection | MEXICHEM FLUOR S.A. DE C.V. |
| 17944637 | PHARMACEUTICAL COMPOSITION | Final Rejection | MEXICHEM FLUOR S.A. DE C.V. |
| 17944666 | PHARMACEUTICAL COMPOSITION | Final Rejection | MEXICHEM FLUOR S.A. DE C.V. |
| 18488375 | PHARMACY COMPOUNDED PRESCRIPTION COMPOSITIONS FOR HAIR GROWTH | Non-Final OA | REMI MEDICAL, LLC |
| 18378743 | CONTROLLED RELEASE OF SUBSTANCES FROM A SOURCE MATERIAL | Final Rejection | Syqe Medical Ltd. |
| 18552171 | Emulsion | Final Rejection | Animal Health Concepts B.V. |
| 17914308 | BISMUTH THIOL COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATING MICROBIAL CO-INFECTIONS | Non-Final OA | Microbion Corporation |
| 18265463 | METHOD FOR MANUFACTURING AN INHALABLE POWDER COMPRISING VORICONAZOLE | Final Rejection | Zambon S.p.A. |
| 18249530 | GOLD CLUSTERS, COMPOSITIONS, AND METHODS FOR TREATMENT OF CEREBRAL STROKES | Non-Final OA | SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD. |
| 18245053 | USE OF ACTIVE SUBSTANCES WITH ANTIVIRAL, ANTI MALARIAL, AND/OR MUCOLYTIC PROPERTIES IN THE TREATMENT OF VIRAL LUNG DISEASES INCLUDING COVID-19 BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE | Final Rejection | ISTANBUL UNIVERSITESI REKTOLUGU |
| 17028595 | INHALED IMATINIB FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) | Non-Final OA | AVALYN PHARMA INC. |
| 18012110 | FORMULATIONS INCLUDING 5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDE | Final Rejection | Mylan Pharma UK Limited |
| 17997981 | INHALED STATINS FOR TREATMENT OF VIRAL RESPIRATORY DISEASES | Final Rejection | InVixa, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy